Feasibility and Acceptability of an Web-based Physical Activity Program, for Those Diagnosed With Lung Cancer.

NCT05121259 | Completed

• 1 other identifier: RS145-281450-JC
• Study Type: interventional
• Target: 18
• Locations: 1 country
• Sites: 1

Brief Summary

Lung cancer is a life changing disease which can cause negative effects on an individual's ability to perform daily tasks and their quality of life (QoL). Lung cancer is the third most common cancer in the UK and is estimated affects approximately 33,000 individuals per year. The most common side effects from lung cancer and treatments are breathlessness, fatigue, nausea, diarrhoea, and depression. Those living beyond cancer often suffer from extreme feelings of isolation and have increased chance of cardiovascular disease and diabetes. Physical activity is a vital component of the prevention and management of cancer. Being active can improve one's physical health (ability to carry out tasks of daily living and breathlessness) and emotional wellbeing (feelings of depression and isolation). Electronic platforms (websites and mobile applications) are increasingly popular within developing nations, particularly with products that aim to increase and keep track of physical activity. Though, literature suggests older adults prefer websites opposed to mobile applications. Online delivery of physical activity could be highly beneficial for patients living with and beyond cancer, reducing the location-based inequality of those who can not attend face-to-face programmes, allowing individuals to carry out a session whenever they can, in the comfort of their own home. Exploring how those living with and beyond lung cancer use a website and investigating the feasibility and acceptability on an online platform which aims to provide tailored physical activity programs will provide fundamental data and possible supporting data for a randomised controlled trail (RCT).

Conditions

Lung Cancer; Survivorship

Keywords

Physical Activity; Exercise; Digtial Technology

Outcome Measures

Primary Outcomes (3)

• The recruitment rate (Website Feasibility)

  The recruitment rate will be established by the number of potential participants approached and how many agree to participate. The recruitment rate will be provided in a factorial or percentage format.

  39 weeks

• The retention rate (Website Feasibility)

  The retention rate will be given based on the initial value of those who provide consent vs those who complete the eight-week intervention. The retention rate will be provided in a factorial or percentage format.

  39 weeks

• Participant Satisfaction (Acceptability)

  The metric which will be assessed to explore acceptability will be satisfaction. Satisfaction will be explored in four approaches: 1. Satisfaction via research team developed questionnaire. The questionnaire will be a five-point Likert scale reporting method from "Strongly Agree" to "Strongly Disagree" in relation to their agreement to statements. 2. Real-time open-ended feedback will be collected upon the first completion of a module 3. Systems Usability Scale (Brooke, 1986). The 10-item questionnaire will provide a five-point Likert scale reporting method from "Strongly Agree" to "Strongly Disagree" in relation to their agreement to statements. 4. A selection of participants based on recruitment will be asked to take part in an interview to further explore satisfaction and acceptability. An interview guide covering the experience of using the website, concerns, and suggested revisions will be followed. The interviews will be transcribed verbatim and analysed.

  39 weeks

Secondary Outcomes (7)

• Quality of Life (or Global Health Status) will be assessed using the EORTC QLQ-C30 (version 3).

  Eight weeks

• Fatigue will be assessed using the EORTC QLQ-C30 (version 3

  Eight weeks

• Pain will be assessed using the EORTC QLQ-C30 (version 3)

  Eight weeks

• Breathlessness

  Eight weeks

• Physical Functioning

  Eight weeks

Study Arms (1)

Exercise Guide

EXPERIMENTAL

Single group feasibility group. Single group (intervention group) will be given access to the intervention (Exercise Guide UK) for eight-weeks.

Other: ExerciseGuide Intervention Group

Interventions

ExerciseGuide Intervention Group OTHER

The single group which will be given access to the eight-week ExerciseGuide UK website containing a tailored physical activity programme and supportive and educational resources.

Exercise Guide

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Be 18 years of age or older.
• Have had a lung cancer diagnosis.
• Be able to speak and read in English.
• Willing and able to provide informed consent.
• Have internet connectivity.
• Access to a laptop, computer, or smart device to access the web-based platform.

You may not qualify if:

• Psychological or linguistic inability to provide informed consent.
• Physical or psychological impairments which prevent or inhibit participation in physical activity. Examples include:
• Uncontrolled atrial fibrillation
• Abdominal aortic aneurysm (AAA)
• Recent heart attack (less than one year)
• Recent stroke (less than one year)
• Psychiatric disorder
• Those who lack capacity under the Mental Capacity Act 2005 (MCA).

Sponsors & Collaborators

• University of Hull: lead
• Hull University Teaching Hospitals NHS Trust: collaborator

Study Sites (1)

Queen's Centre for Oncology and Haematology (Castle Hill)

Hull, East Riding Of Yorkshire, HU16 5JQ, United Kingdom

Location

Related Publications (1)

• Curry J, Lind M, Short CE, Vandelanotte C, Evans HEL, Pearson M, Forbes CC. Evaluating a web-based computer-tailored physical activity intervention for those living with and beyond lung cancer (ExerciseGuide UK): protocol for a single group feasibility and acceptability study. Pilot Feasibility Stud. 2022 Aug 13;8(1):182. doi: 10.1186/s40814-022-01129-6.

  PMID: 35964141 DERIVED

MeSH Terms

Conditions

Lung Neoplasms; Motor Activity

Condition Hierarchy (Ancestors)

Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases; Behavior

Study Officials

• Cynthia C Forbes, PhD

  University of Hull

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Career Development Fellow

Model Details: Single group feasibility study. Upon obtaining informed consent, participants will be allocated to the intervention group.

Study Record Dates

• First Submitted: October 20, 2021
• First Posted: November 16, 2021
• Study Start: November 22, 2021
• Primary Completion: August 8, 2022
• Study Completion: August 11, 2022
• Last Updated: November 1, 2022

Record last verified: 2022-10

Data Sharing

• IPD Sharing: Will not share

Locations

GB (1)